TLSI insider filings

TriSalus Life Sciences, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-19. Screen TLSI transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 8 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Szela Mary T — CEO and President, Director22 legs · 65,192 sh · $160,205—1
Wahlstrom Mats — Director11 leg · 50,000 sh · $112,000——
Gordon Gary B. — Director11 leg · 10,000 sh · $22,000——
Marshak Richard — Chief Commercial Officer2—2 legs · 869 sh · $2,749—
Stevens Jennifer — Chief Regulatory Officer1—1 leg · 316 sh · $1,387—
Cox Bryan F. — Chief of Research1—1 leg · 296 sh · $1,299—

Recent insider filings — TriSalus Life Sciences, Inc.

FiledFormInsiderReported transactionsSource
2026-11-194Gordon Gary B. — DirectorPurchase (P): 10,000 @ $2.20EDGAR
2026-11-194Szela Mary T — CEO and President, DirectorPurchase (P): 30,864 @ $2.31 · Purchase (P): 34,328 @ $2.59EDGAR
2026-11-174Marshak Richard — Chief Commercial OfficerSale (S): 544 @ $2.43EDGAR
2026-11-164Wahlstrom Mats — DirectorPurchase (P): 50,000 @ $2.24EDGAR
2026-10-074Szela Mary T — CEO and President, DirectorTax withholding (F): 2,693 @ $4.38EDGAR
2026-10-074Stevens Jennifer — Chief Regulatory OfficerSale (S): 316 @ $4.39EDGAR
2026-10-074Marshak Richard — Chief Commercial OfficerSale (S): 325 @ $4.39EDGAR
2026-10-074Cox Bryan F. — Chief of ResearchSale (S): 296 @ $4.39EDGAR
2026-07-064Patience David — Chief Financial OfficerTax withholding (F): 14,650 @ $4.46EDGAR
2026-07-014Marshak Richard — Chief Commercial OfficerGrant/award (A): 561 @ $3.87EDGAR
2026-07-014Szela Mary T — CEO and President, DirectorGrant/award (A): 3,990 @ $3.87EDGAR
2026-06-294Marshall Richard Henry — Chief Medical OfficerGrant/award (A): 60,000 @ $0 · Grant/award (A): 120,000 (derivative) @ $0EDGAR
2026-05-194Marshak Richard — Chief Commercial OfficerSale (S): 543 @ $2.67EDGAR
2026-05-184Patience David — Chief Financial OfficerPurchase (P): 7,100 @ $2.43EDGAR
2026-05-184Gordon Gary B. — DirectorPurchase (P): 10,000 @ $2.46EDGAR
2026-05-184Wahlstrom Mats — DirectorPurchase (P): 60,000 @ $2.53EDGAR
2026-05-184Stansky Michael P — DirectorPurchase (P): 410,000 @ $2.50 · Purchase (P): 200,000 @ $2.50EDGAR
2026-05-184Szela Mary T — CEO and President, DirectorPurchase (P): 39,682 @ $2.59EDGAR
2026-05-154Valle William — DirectorGrant/award (A): 28,201 @ $0 · Grant/award (A): 24,553 @ $0 · Grant/award (A): 56,403 (derivative) @ $0EDGAR
2026-05-154Gordon Gary B. — DirectorGrant/award (A): 28,201 @ $0 · Grant/award (A): 24,553 @ $0 · Grant/award (A): 56,403 (derivative) @ $0EDGAR
2026-05-154Wahlstrom Mats — DirectorGrant/award (A): 37,602 @ $0 · Grant/award (A): 34,226 @ $0 · Grant/award (A): 75,204 (derivative) @ $0EDGAR
2026-05-154Stansky Michael P — DirectorGrant/award (A): 23,501 @ $0 · Grant/award (A): 20,089 @ $0 · Grant/award (A): 47,003 (derivative) @ $0EDGAR
2026-05-154MATLIN DAVID J — DirectorGrant/award (A): 28,201 @ $0 · Grant/award (A): 23,065 @ $0 · Grant/award (A): 56,403 (derivative) @ $0EDGAR
2026-05-154HICKS KERRY R — DirectorGrant/award (A): 28,201 @ $0 · Grant/award (A): 56,403 (derivative) @ $0EDGAR
2026-04-204Frankenius Equity AB — 10% ownerConversion (C): 759,000 @ $0 · Conversion (C): 230,000 (derivative) @ $0EDGAR
2026-04-014MATLIN DAVID J — DirectorConversion (C): 330,000 @ $0 · Conversion (C): 100,000 (derivative) @ $0EDGAR
2026-03-204Devlin Jodi — Chief of Clinical OperationsSale (S): 1,162 @ $4.13 · Sale (S): 1,772 @ $4.09 · Sale (S): 273 @ $4.12EDGAR
2026-03-204Cox Bryan F. — Chief of ResearchSale (S): 1,138 @ $4.13 · Sale (S): 1,467 @ $4.09 · Sale (S): 579 @ $4.12EDGAR
2026-03-204Marshak Richard — Chief Commercial OfficerSale (S): 1,449 @ $4.13 · Sale (S): 1,589 @ $4.09 · Sale (S): 419 @ $4.12EDGAR
2026-03-204Stevens Jennifer — Chief Regulatory OfficerSale (S): 1,204 @ $4.13 · Sale (S): 1,552 @ $4.09 · Sale (S): 774 @ $4.12EDGAR
2026-03-204Szela Mary T — CEO and President, DirectorSale (S): 4,358 @ $4.13 · Sale (S): 15,944 @ $3.85EDGAR
2026-02-234Patience David — Chief Financial OfficerPurchase (P): 3,657 @ $4.10EDGAR
2026-02-234Valle William — DirectorPurchase (P): 30,487 @ $4.10EDGAR
2026-02-234Gordon Gary B. — DirectorPurchase (P): 9,756 @ $4.10EDGAR
2026-02-234Stansky Michael P — DirectorPurchase (P): 243,900 @ $4.10 · Purchase (P): 117,198 @ $4.10EDGAR
2026-02-234Szela Mary T — CEO and President, DirectorPurchase (P): 30,487 @ $4.10EDGAR
2026-02-114Stansky Michael P — DirectorGrant/award (A): 92,537 (derivative) @ $0EDGAR
2025-11-254Devlin Jodi — Chief of Clinical OperationsGrant/award (A): 50,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2025-11-254Marshak Richard — Chief Commercial OfficerGrant/award (A): 60,000 @ $0 · Grant/award (A): 120,000 (derivative) @ $0EDGAR
2025-11-254Stevens Jennifer — Chief Regulatory OfficerGrant/award (A): 50,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2025-11-254Cox Bryan F. — Chief of ResearchGrant/award (A): 40,000 @ $0 · Grant/award (A): 80,000 (derivative) @ $0EDGAR
2025-11-254Patience David — Chief Financial OfficerGrant/award (A): 65,000 @ $0 · Grant/award (A): 130,000 (derivative) @ $0EDGAR
2025-11-254Szela Mary T — CEO and President, DirectorGrant/award (A): 125,000 @ $0 · Grant/award (A): 125,000 @ $0 · Grant/award (A): 300,000 @ $0 · Grant/award (A): 250,000 (derivative) @ $0EDGAR
2025-08-294Patience David — Chief Financial OfficerGrant/award (A): 248,899 (derivative) @ $0EDGAR
2025-08-154Patience David — Chief Financial OfficerGrant/award (A): 200,000 @ $0 · Grant/award (A): 290,000 (derivative) @ $0EDGAR
2025-06-274Gordon Gary B. — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2025-06-274Murphy Sean — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2025-06-274Wahlstrom Mats — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2025-06-274MATLIN DAVID J — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2025-06-274HICKS KERRY R — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR

Recent 8-K events — TriSalus Life Sciences, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-108-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-228-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-148-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-298-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-04-078-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-208-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-098-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=TLSI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs